0001437749-20-024043.txt : 20201116
0001437749-20-024043.hdr.sgml : 20201116
20201116211347
ACCESSION NUMBER: 0001437749-20-024043
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200722
FILED AS OF DATE: 20201116
DATE AS OF CHANGE: 20201116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DE GREEF RODERICK
CENTRAL INDEX KEY: 0001241181
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 201319072
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4/A
1
rdgdoc.xml
FORM 4/A
X0306
4/A
2020-07-22
2020-07-24
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001241181
DE GREEF RODERICK
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
CFO & COO
Common Stock
2020-07-22
4
A
0
100000
A
158074
D
This Form 4/A is being filed to amend the Form 4 (the "Original Form 4") filed by the reporting person on July 24, 2020 to include the restricted stock grant that was granted on July 22, 2020 pursuant to the BioLife Solutions Inc. Second Amended and Restated 2013 Performance Incentive Plan, on Table I rather than Table II. As described in the Original Form 4, the restricted stock vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The information included in column 5 of this Form 4/A reflects the number of securities beneficially owned following the reported transaction on July 22, 2020 assuming all of the restricted shares vested.
/s/ Roderick de Greef
2020-11-16